Litigation Details for Cytiva Sweden AB v. Bio-Rad Laboratories, Inc. (D. Del. 2018)
✉ Email this page to a colleague
Cytiva Sweden AB v. Bio-Rad Laboratories, Inc. (D. Del. 2018)
Docket | ⤷ Sign Up | Date Filed | 2018-11-29 |
Court | District Court, D. Delaware | Date Terminated | |
Cause | 35:271 Patent Infringement | Assigned To | Colm Felix Connolly |
Jury Demand | Plaintiff | Referred To | Sherry R. Fallon |
Patents | 8,535,536; 8,663,194; 9,095,404 | ||
Link to Docket | External link to docket |
Biologic Drugs cited in Cytiva Sweden AB v. Bio-Rad Laboratories, Inc.
The biologic drugs covered by the patents cited in this case are ⤷ Sign Up , ⤷ Sign Up , and ⤷ Sign Up .
Details for Cytiva Sweden AB v. Bio-Rad Laboratories, Inc. (D. Del. 2018)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2021-01-18 | 224 | Exhibit A-S | Stephenson, Bruce K. Gale, and Cynthia Furse. 9. Patent No. 8,535,536 Cross-flow split-thin-flow cell, Bruce K… in the asserted patents and the representations the inventors made to the patent office to obtain …analysis of the patent, the statements the inventors made to obtain their patents, and the actual modules…591 Patent 1. The NGC System Does Not Infringe Claim 9 of the ’591 Patent at … claim 1 of the ’591 patent is nearly identical to claim 1 of the ’420 patent. Thus, I incorporate | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |